Cystic Fibrosis

Trikafta in Cystic Fibrosis Patients

Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) Long-term Safety and Efficacy in Subjects Without F508del

Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

Continuous Glucose Monitoring and OGTT Screen for Cystic Fibrosis Related Diabetes in Cystic Fibrosis

Impact of Telerehabilitation Training on Pediatric Cystic Fibrosis Patients: An Exploratory Study

Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis

HERO-2: Home-Reported Outcomes With CFTR Modulator Therapy

Natural History of Noncirrhotic Portal Hypertension

A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions

Role of Genetic Factors in the Development of Lung Disease

Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants

A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa

Natural History of Bronchiectasis

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

High Resolution Micro OCT Imaging

Osteopathic Treatment in Adult Patients With Cystic Fibrosis

Quantitation and Spatial Registration of Airways Dysfunction With Dynamic 19F MRI in Cystic Fibrosis